SCHEMBL7659462

SCHEMBL7659462

CCCCc1nc(-c2ccccc2F)n[nH]1

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DDX3X O00571 1/20 0.43
LMNA P02545 1/20 0.41
NR1H2 P55055 1/20 0.40
NR1H3 Q13133 1/20 0.40
MAPT P10636 1/20 0.39
GCGR P47871 1/20 0.39
TLR8 Q9NR97 1/20 0.39
DCUN1D1 Q96GG9 1/20 0.38
PARP1 P09874 1/20 0.38
ADORA3 P0DMS8 2/20 0.37
ADORA2A P29274 2/20 0.37
ADORA1 P30542 2/20 0.37
SUCNR1 Q9BXA5 1/20 0.36
ALPL P05186 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1899895 0.78 NR1H2 (0.58) DDX3XLMNANR1H2NR1H3PARP1
SCHEMBL26108539 0.74 ADORA2A (0.47) DDX3XLMNANR1H2NR1H3ADORA2A
SCHEMBL27880002 0.73 SMN1; SMN2 (0.56) DDX3XLMNAMAPTALPL
SCHEMBL15026752 0.73 DDX3X (0.43) DDX3XNR1H2NR1H3MAPTADORA2A
SCHEMBL29109555 0.73 DDX3X (0.40) DDX3XLMNAMAPTPARP1SUCNR1
SCHEMBL31228708 0.72 NR1H2 (0.50) LMNANR1H2NR1H3ADORA2AALPL
SCHEMBL26108844 0.72 NR1H2 (0.50) LMNANR1H2NR1H3ADORA2AALPL
SCHEMBL7654725 0.71 ROCK2 (0.53) DDX3XMAPT
SCHEMBL7661209 0.71 HPGD (0.45) DDX3XLMNAMAPTADORA3ADORA2A
SCHEMBL27968243 0.71 CCR1 (0.43) DDX3XLMNANR1H2NR1H3PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358984-B1 FOR THERAPY OF HYPERTENSION AND/OR DISEASES SUCH AS HEART AND RENAL DISEASES LEAD CHEMICAL CO., LTD. (JP) 2002-03-19 US disclosed
US-6232335-B1 A BIPHENYL TRIAZOLE COMPOUND USEFUL AS A ANGIOTENSIN II CONVERTING ENZYME INHIBITORS EFFECTIVE IN THE TREATMENT OF HYPERTENSION OR HEART FAILURE LEAD CHEMICAL CO., LTD. (JP) 2001-05-15 US disclosed
EP-0936221-A1 NOVEL 2,4-DIOXOPYRROLIDINE AND 2,4-DIOXOTETRAHYDROFURAN DERIVATIVES AND MEDICINES CONTAINING THE SAME AS THE ACTIVE INGREDIENT LEAD CHEMICAL COMPANY LTD. (JP) 1999-08-18 EP disclosed